期刊文献+

盐酸氨溴索氧驱雾化吸入治疗小儿急性毛细支气管炎疗效观察 被引量:12

Observing the effect of oxygen atomized inhalation of ambroxol to treat infants with bronchiolitis
下载PDF
导出
摘要 目的观察氧驱雾化吸入盐酸氨溴索治疗小儿急性毛细支气管炎的临床疗效。方法选择小儿急性毛细支气管炎106例,随机分为2组。观察组盐酸氨溴索7.5mg/次,2次/d,采用氧驱动雾化吸入,对照组采用超声雾化吸入,盐酸氨溴索7.5mg/次,2次/d,观察其临床症状体征消失的时间。结果观察组在临床症状和肺部哮鸣音消失时间、平均治疗时间上明显短于对照组,P<0.01,差异有统计学意义。结论盐酸氨溴索氧驱雾化治疗小儿急性毛细支气管炎疗效显著,值得推广。 Objective To observe the clinical effect of oxygen atomized inhalation of ambroxol in the treatment of infants with bronchiolitis. Methods 106 cases of infant bronchopneumonia were randomly divided into two groups: the treatment group (50cases)were treated with oxygen atomized inhalation of ambroxol (7.5 rag,bid) ,while the control group (56cases)were treated with ultrasonic atomized inhalation of ambroxol (7. 5 mg, bid), observing its disappeared time of clinical symptom and objective sign. Results the cough, shortness breath improving time and rale disappearing time and the mean length of treatmention of treatment group were shorter than those of the control group ( P 〈 0. 01 ). The difference was remarkable. Conclusion the effect of oxygen atomized inhalation of ambroxol to treat infants with bronchiolitis is significant and worth of spreading.
作者 尚玉芝
出处 《中国现代药物应用》 2009年第12期15-16,共2页 Chinese Journal of Modern Drug Application
关键词 盐酸氨溴索 氧驱动雾化吸入 超声雾化吸入 毛细支气管炎 Ambroxol Oxygen atomizing inhalation Ultrasonic atomizing inhalation Bronchiolitis
  • 相关文献

参考文献4

二级参考文献19

  • 1儿童哮喘诊断标准和治疗常规[J].中华儿童保健杂志,1993,1(4):249-251. 被引量:325
  • 2小儿哮喘的治疗[J].中国实用儿科杂志,1996,11(1):1-21. 被引量:110
  • 3Lusuardi M,Cape 1 li A,Carli S,etal.Role of surfactant in chronic obst ructive pulmonary disease:therapeuticimplications.Respiration,1992,59(Suppl 1): 28-32.
  • 4Gillissen A,Nowak D.Characterization of N-acetylcysteine and ambroxol inanti-oxedant therapy.Respir Med,1998,92(4):609-623.
  • 5Houtmeyers E.Effects of drugs on mucus clearance.Eur Respir J,1999,1 4(2):452-467.
  • 6Zasshi NY.Effects of ambroxol HC1 on the guinea pig tracheal mucous secretion andthe rat pulmonary surfactant secretion.Uchida-M,1992,100(4):293-30 0.
  • 7Derelle J,Bertolo HE,Marchal F,et al.Respiratory evolution of patien t withmucoviscidosis treated with mucolytic agents plus dornase alfa.Arch-Pediatr,1998,5(4):371-377.
  • 8Nowak D,Antczak A,Krol M,et al.Antioxidant properties of ambroxol.Fr ee Radic BiolMed,1994,16(4):517-522.
  • 9Zwablo KG,Servais MD,Schmutzler W,et al.Ambroxol inhibits histamine release fromhuman adenoidal mast cells.Inflamm Res,1998,47(Suppl 1):S16-17.
  • 10Dorow P,Weiss T.Modification of mucociliary clearance by a combinati on oftheophylline with ambroxol and of ambroxol in monotherapy.Arzneimittelforschung,1988,38(6):828-830.

共引文献252

同被引文献141

引证文献12

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部